- Home
- JPC
as 12-17-2024 4:00pm EST
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 2.6B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 998.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $5.94 - $7.36 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Nuveen Preferred & Income Opportunities Fund News
JPC Breaking Stock News: Dive into JPC Ticker-Specific Updates for Smart Investing
PR Newswire
a year ago
Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education
Zacks
a year ago
Griffon (GFF) to Report Q1 Earnings: Is a Beat in Store?
InvestorPlace
a year ago
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
Simply Wall St.
a year ago
TriCo Bancshares Full Year 2023 Earnings: EPS Misses Expectations
GlobeNewswire
a year ago
Kayne Anderson Energy Infrastructure Fund Files 2023 Annual Report
Yahoo Finance Video
a year ago
Boeing crisis to hinder airlines, hit economy: Expert
PR Newswire
a year ago
CleanSpark Executives to Discuss Fiscal First Quarter 2024 Financial Results Via Webcast
Zacks
a year ago
Wall Street Analysts Think Edgewise Therapeutics, Inc. (EWTX) Could Surge 70.76%: Read This Before Placing a Bet
Compare JPC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JPC Nuveen Preferred & Income Opportunities Fund - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.